SG Americas Securities
INBX icon

SG Americas Securities’s Inhibrx INBX Stock Holding History

SG Americas Securities’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+12,466
New +$1.25M ﹤0.01% 1772
2026
Q1 		– Sell
-16,088
Closed -$1.27M – 3458
2025
Q4 		$1.27M Buy
+16,088
New +$1.1M ﹤0.01% 1813

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's INBX Position: Q2 2026 in Review

SG Americas Securities opened a new position in Inhibrx (INBX) in Q2 2026: 12,466 shares worth $1.18M. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in INBX as recently as Q4 2025.

SG Americas Securities first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.27M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • SG Americas Securities held 12,466 shares of Inhibrx worth $1.18M as of Q2 2026.
  • Inhibrx was a new SG Americas Securities position in Q2 2026.
  • Inhibrx made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1772 holding.
  • SG Americas Securities first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
  • SG Americas Securities's Inhibrx position peaked at $1.27M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.